The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
MIRROS: An ongoing randomized phase 3 trial of idasanutlin + ARA-C in patients with relapsed or refractory acute myeloid leukemia.
 
Pau Montesinos
Consulting or Advisory Role - Abbvie; Celgene; Daiichi Sankyo; Jazz Pharmaceuticals; Novartis; Pfizer; Shire
Speakers' Bureau - Celgene; Daiichi Sankyo; Otsuka
Research Funding - Celgene (Inst); Janssen-Cilag (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen
 
Jordi Esteve
Consulting or Advisory Role - Amgen; Celgene; Daiichi Sankyo; Jazz Pharmaceuticals; Novartis
Travel, Accommodations, Expenses - Celgene; Daiichi Sankyo; Janssen
 
Marina Konopleva
Stock and Other Ownership Interests - Reata Pharmaceuticals
Honoraria - Abbvie; Calithera Biosciences; Genentech
Consulting or Advisory Role - AbbVie; Cellectis; Genentech/Roche; Stemline Therapeutics
Research Funding - Abbvie (Inst); Ablynx (Inst); Calithera Biosciences (Inst); Cellectis (Inst); Genentech (Inst); Lilly (Inst); Roche (Inst); Stemline Therapeutics (Inst)
 
Giovanni Martinelli
Honoraria - Abbvie; Celgene; Daiichi Sankyo; Incyte; Roche
Consulting or Advisory Role - Abbvie; Celgene; Daiichi Sankyo; Incyte; Pfizer; Roche; Takeda
Speakers' Bureau - Abbvie; Celgene; Pfizer; Takeda
Research Funding - Celgene; Daiichi Sankyo; Pfizer
Travel, Accommodations, Expenses - Abbvie; Celgene; Daiichi Sankyo; Roche; Takeda
 
Oliver Ottmann
Honoraria - Amgen; Celgene; Fusion Antibodies; Incyte; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; Celgene; Fusion Antibodies; Incyte; Novartis; Pfizer; Roche
Research Funding - Amgen; Celgene; Incyte
Travel, Accommodations, Expenses - Amgen; Celgene; Incyte; Novartis
 
Rebeca Rodriguez-Veiga
Consulting or Advisory Role - Gamida Cell; Menarini
Travel, Accommodations, Expenses - Amgen; Daiichi Sankyo; Janssen; Menarini; Pfizer; Sanofi; Teva
 
Christoph Röllig
Consulting or Advisory Role - AbbVie; Amgen; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Janssen; Jazz Pharmaceuticals; Novartis; Pfizer; Roche; Takeda
Speakers' Bureau - Jazz Pharmaceuticals
 
Andrew Wei
Honoraria - Abbvie/Genentech; Amgen; Celgene; Janssen Oncology; Novartis; Pfizer; Roche; SERVIER
Consulting or Advisory Role - Abbvie/Genentech; Amgen; Novartis; SERVIER
Speakers' Bureau - Abbvie/Genentech; Novartis
Research Funding - Celgene (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - AW is a former employee of the Walter and Eliza Hall Institute which receives milestone and royalty payments related to venetoclax, and is eligible for benefits related to these payments. AW receives payments from WEHI related to venetoclax
Expert Testimony - Amgen
Travel, Accommodations, Expenses - Abbvie; Amgen; Celgene; Novartis
 
Norbert Vey
Consulting or Advisory Role - Amgen; Novartis; Roche
Research Funding - Novartis
Travel, Accommodations, Expenses - Roche
 
Idy Chiu
Employment - Roche
 
Annabelle Monnet
Employment - Roche
 
Marion Gabriele Ott
Employment - Roche
Leadership - Roche
Stock and Other Ownership Interests - Roche
Patents, Royalties, Other Intellectual Property - Roche
Travel, Accommodations, Expenses - Roche
 
Pierre Fenaux
No Relationships to Disclose